Results 21 to 30 of about 269,235 (359)
A rare case of ovarian vein thrombosis in a gestational trophoblastic neoplasia patient [PDF]
Obstetrics & Gynecology Science, 2019 Ovarian vein thrombosis (OVT) is a rare disease with complications that can be life-threatening. An ovarian vein thrombus in a gestational trophoblastic neoplasia (GTN) is an extremely rare condition that has not been previously reported in the ...
In Young Kim +4 more
doaj +1 more source
Journal of Pharmacy and Pharmacology, 1949 Abstract The processes that underly the clotting of blood are still far from adequately understood, in spite of the many facts uncovered by generations of patient investigators. The classical scheme associated with the name of Morawitz1, although neither complete nor universally accepted, is still useful as a summary of the main events ...
openaire +3 more sources
Journal of Arrhythmia, 2022 Background Adherence to direct oral anticoagulants (DOACs) remains a concern among non‐valvular atrial fibrillation (AF) patients. We aimed to assess patterns of adherence with DOACs and examine their association with ischemic stroke and systemic ...
Anat Arbel +4 more
doaj +1 more source
MAC Project—Monitoring Anticoagulant Therapy Observational Study: Rationale and Protocol
Frontiers in Medicine, 2021 Real-life studies complement data from registrative trials. Because of the delayed registration of direct oral anticoagulants in Italy, scarce real-life data on such treatments is available for the Italian population.
Giuseppe Camporese +11 more
doaj +1 more source
Assessment of knowledge and practice of cardiovascular nurses regarding warfarin
Journal of Education and Health Promotion, 2022 BACKGROUND: Despite new anticoagulants' developments, warfarin is still one of the most commonly used medicines, particularly in the cardiovascular system.
Maryam Ehsani +4 more
doaj +1 more source
Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum
American journal of hematology/oncology, 2019 Two specific reversal agents for direct oral anticoagulants (DOACs) have been approved in the United States: idarucizumab for dabigatran reversal and andexanet alfa for apixaban and rivaroxaban reversal.
A. Cuker +7 more
semanticscholar +1 more source
Anticoagulation in cirrhosis [PDF]
Liver International, 2012 The Authors review and comment a recent publication by Senzolo et al.
VILLA, Erica, N. De Maria
openaire +4 more sources
Безопасность и риск фармакотерапии, 2019 New oral anticoagulants are effective for the prevention of thromboembolic complications in patients with atrial fibrillation, or after orthopedic surgery.
A. P. Pereverzev +3 more
doaj +1 more source
Frontiers in Veterinary Science, 2022 BackgroundEvaluation of mineral profiles including essential and toxic elements in dairy cows provides fundamental information for bovine practitioners during regular herd supervision and monitoring.
Hussein Awad Hussein +2 more
doaj +1 more source
Journal of Thrombosis and Haemostasis, 2018 Click to hear Dr Baglin's perspective on the role of the laboratory in treatment with new oral ...
J. Douxfils +8 more
semanticscholar +1 more source